Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-13-000755
Filing Date
2013-11-27
Accepted
2013-11-27 15:21:55
Documents
2
Group Members
ALKALOIDA CHEMICAL CO EXCLUSIVE GROUP LTD.CARACO PHARMACEUTICAL LABORATORIES, LTD.SUN PHARMA GLOBAL INC.TARO DEVELOPMENT CORP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 26 TO SCHEDULE 13D ss195452_sc13da.htm SC 13D/A 261341
2 THIRD JOINDER AGREEMENT ss195452_ex9953.htm EX-99.53 6055
  Complete submission text file 0000947871-13-000755.txt   269253
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000906338 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49231 | Film No.: 131247581
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093
Business Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093 01191228212128
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0001197089 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations